These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 25758127)

  • 1. Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin.
    Shi Y; Liu X; Sun Y; Wu D; Qiu A; Cheng H; Wu C; Wang X
    J Mol Histol; 2015 Apr; 46(2):221-31. PubMed ID: 25758127
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased Expression of EHD2 Promotes Tumor Metastasis and Indicates Poor Prognosis in Hepatocellular Carcinoma.
    Liu J; Ni W; Qu L; Cui X; Lin Z; Liu Q; Zhou H; Ni R
    Dig Dis Sci; 2016 Sep; 61(9):2554-67. PubMed ID: 27221498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.
    Liu X; Yao N; Qian J; Huang H
    Med Oncol; 2014 Mar; 31(3):878. PubMed ID: 24522810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Low expressions of EHD2 and E-cadherin correlate with a poor prognosis for clear cell renal cell carcinoma].
    Ye M; Fan G; Zhu S; Han W; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 44(8):864-870. PubMed ID: 31570672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of EHD2 in migration and invasion of human breast cancer cells.
    Yang X; Ren H; Yao L; Chen X; He A
    Tumour Biol; 2015 May; 36(5):3717-26. PubMed ID: 25557791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of EHD2 interference on migration of esophageal squamous cell carcinoma.
    Li M; Yang X; Zhang J; Shi H; Hang Q; Huang X; Liu G; Zhu J; He S; Wang H
    Med Oncol; 2013 Mar; 30(1):396. PubMed ID: 23354948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.
    Zhu T; Ji Z; Xu C; Peng Z; Gu L; Zhang R; Liu Y
    J Mol Histol; 2014 Dec; 45(6):665-77. PubMed ID: 25027991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic values of osteopontin-c, E-cadherin and β-catenin in breast cancer.
    Pang H; Lu H; Song H; Meng Q; Zhao Y; Liu N; Lan F; Liu Y; Yan S; Dong X; Cai L
    Cancer Epidemiol; 2013 Dec; 37(6):985-92. PubMed ID: 24012693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.
    Wang H; Liu XB; Chen JH; Wang QQ; Chen JP; Xu JF; Sheng CY; Ni QC
    Exp Mol Pathol; 2014 Oct; 97(2):191-201. PubMed ID: 25036402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MTBP Promotes the Invasion and Metastasis of Hepatocellular Carcinoma by Enhancing the MDM2-Mediated Degradation of E-Cadherin.
    Lu S; Zhou W; Wei H; He L; Li L
    Dig Dis Sci; 2015 Dec; 60(12):3681-90. PubMed ID: 26280083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
    Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
    Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and prognostic role of SKIP in human breast carcinoma.
    Liu X; Ni Q; Xu J; Sheng C; Wang Q; Chen J; Yang S; Wang H
    J Mol Histol; 2014 Apr; 45(2):169-80. PubMed ID: 24150787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Negative/low HER2 expression alone or combined with E-cadherin positivity is predictive of better prognosis in patients with breast carcinoma.
    Karray-Chouayekh S; Trifa F; Khabir A; Sellami-Boudawara T; Frikha M; Gargouri A; Mokdad-Gargouri R
    Histol Histopathol; 2012 Mar; 27(3):377-85. PubMed ID: 22237715
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation and expression of p53, HER-2, vascular endothelial growth factor (VEGF), and e-cadherin in a high-risk breast-cancer population.
    Howard EM; Lau SK; Lyles RH; Birdsong GG; Tadros TS; Umbreit JN; Kochhar R
    Int J Clin Oncol; 2004 Jun; 9(3):154-60. PubMed ID: 15221598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of SNAIL and TWIST determines prognosis in estrogen receptor-positive early breast cancer patients.
    van Nes JG; de Kruijf EM; Putter H; Faratian D; Munro A; Campbell F; Smit VT; Liefers GJ; Kuppen PJ; van de Velde CJ; Bartlett JM
    Breast Cancer Res Treat; 2012 May; 133(1):49-59. PubMed ID: 21796367
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EHD2 Overexpression Suppresses the Proliferation, Migration, and Invasion in Human Colon Cancer.
    Guan C; Lu C; Xiao M; Chen W
    Cancer Invest; 2021 Apr; 39(4):297-309. PubMed ID: 33356637
    [No Abstract]   [Full Text] [Related]  

  • 17. CRH suppressed TGFβ1-induced Epithelial-Mesenchymal Transition via induction of E-cadherin in breast cancer cells.
    Jin L; Chen J; Li L; Li C; Chen C; Li S
    Cell Signal; 2014 Apr; 26(4):757-65. PubMed ID: 24412750
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Wei S; Shao J; Wang J; Zhao T; Liu J; Shen X; Wang Y; Chen H; Wang G
    J Thorac Dis; 2022 Jul; 14(7):2652-2664. PubMed ID: 35928621
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatoma-derived growth factor regulates breast cancer cell invasion by modulating epithelial--mesenchymal transition.
    Chen SC; Kung ML; Hu TH; Chen HY; Wu JC; Kuo HM; Tsai HE; Lin YW; Wen ZH; Liu JK; Yeh MH; Tai MH
    J Pathol; 2012 Oct; 228(2):158-69. PubMed ID: 22247069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Claudins as prognostic factors of breast cancer].
    Szász MA
    Magy Onkol; 2012 Sep; 56(3):209-12. PubMed ID: 23139925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.